Pharmaco-metabolomics

Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.

 

    Related Conference of Pharmaco-metabolomics

    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain
    May 24-25, 2027

    23rd World Congress on Structural Biology

    Paris, France

    Pharmaco-metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in